Primenenie kombinatsii β2-agonista i M-kholinolitika dlya lecheniya bronkhial'noy astmy
- Authors: Zykov K.A1
-
Affiliations:
- Московский государственный медико-стоматологический университет
- Issue: Vol 12, No 11 (2010)
- Pages: 4-7
- Section: Articles
- URL: https://bakhtiniada.ru/2075-1753/article/view/93201
- ID: 93201
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
K. A Zykov
Московский государственный медико-стоматологический университетЛаборатория пульмонологии НИМСИ
References
- Riccioni G, D'Orazio N, Di Ilio C et al. Quality of Life and clinical symptoms in asthmatic subjects. J Asthma 2004; 41: 85–9.
- Глобальная стратегия лечения и профилактики бронхиальной астмы. Под ред. А.Г.Чучалина. М.: Изд - кий дом «Атмосфера», 2007.
- Global Initiative for Asthma (GINA) Global strategy for asthma management and prevention. 2006. http://www.ginasthma.com
- Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469–78.
- Емельянов А.В., Федосеев Г.Б., Сергеева Г.Р.и др. Распространенность бронхиальной астмы и аллергического ринита среди взрослого населения Санкт - Петербурга. Аллергология. 2002; 2: 10–5.
- Wertz D.A, Pollack M, Rodgers K. Impact of asthma control on sleep, attendance at work, normal activities, and disease burden. Ann Allergy Asthma Immunol 2010; 105 (2): 118–23.
- Ni Chroinin M, Greenstone I, Lasserson T.J, Ducharme F.M. Addition of inhaled long - acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid - naive adults and children. Cochrane Database Syst Rev. 2009; 4: CD005307.
- Ducharme F.M, Ni Chroinin M, Greenstone I, Lasserson T.J. Addition of long - acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma. Cochrane Database Syst Rev. 2010; 4: CD005533.
- Global Strategy for Asthma Management and Prevention. Revised 2009 The GINA reports are available on www.ginasthma.org
- Gelb A.F, Karpel J, Wise R.A et al. Bronchodilator efficacy of the fixed combination of ipratropium and albuterol compared to albuterol alone in moderate - to - severe persistent asthma. Pulm Pharmacol Ther 2008; 21 (4): 630–6.
- Donohue J. Combination therapy for COPD. Proc Am Thorac Soc 2005; 2: 72–81.
- Ahmad Z, Singh S.K. Relative and additional bronchodilator response of salbutamol and ipratropium in smoker and nonsmoker asthmatics. J Asthma 2010; 47 (3): 340–3.
- Boaventura L.C, Araujo A.C, Martinez J.B, Vianna E.O. Effects of ipratropium on exercise - induced bronchospasm. Int J Sports Med 2010; 31 (7): 516–20.
- Oraka E, King M.E, Callahan D.B. Asthma and serious psychological distress: prevalence and risk factors among US adults, 2001-2007. Chest 2010; 37 (3): 609–16.
- Ritz T, Kullowatz A, Goldman M.D. Airway response to emotional stimuli in asthma: the role of the cholinergic pathway. J Appl Physiol 2010; 108 (6): 1542–9.
- Schlueter D.P. Ipratropium bromide in asthma: A review of the literature The Am J Med 1986; 81 (5, Suppl. 1), 55–60.
- Haney S, Hancox R.J. Overcoming beta - agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials. Respir Res 2007; 6; 8: 19.
Supplementary files
